The present invention relates to an antibacterial agent, which comprises, as an active ingredient, a compound represented by the following general formula (1):
or a pharmaceutically acceptable salt thereof.
本发明涉及一种抗菌剂,其包含以下通式(1)所表示的化合物作为活性成分,或其药学上可接受的盐。
NOVEL 2,4-DIAMINO-1,3,5-TRIAZINE DERIVATIVE
申请人:Hamari Chemicals Co., Ltd.
公开号:EP1574503A1
公开(公告)日:2005-09-14
The present invention relates to an antibacterial agent, which comprises, as an active ingredient, a compound represented by the following general formula (1):
or a pharmaceutically acceptable salt thereof.
本发明涉及一种抗菌剂,其活性成分包括由以下通式(1)代表的化合物:
或其药学上可接受的盐。
US7622469B2
申请人:——
公开号:US7622469B2
公开(公告)日:2009-11-24
2,4-Diamino-1,3,5-triazine derivative
申请人:HAMARI CHEMICALS, LTD.
公开号:EP1574503B1
公开(公告)日:2013-03-13
Membrane permeabilization and perturbation induced by alkyl- biguanidium salts
作者:Audrey Hébert、Maxime Parisotto、Gerardo Ferbeyre、Andreea R. Schmitzer
DOI:10.1080/10610278.2018.1535710
日期:2019.3.4
ABSTRACT Alkylbiguanidium salts show membrane perturbing properties toward simple phospholipid bilayer (liposomes) and complex phospholipid membranes (bacterial membranes). Compared to metformin and phenformin, alkylbiguanidium salts induce a more significant permeabilization of the phospholipid membranes, leading to highly selective H+/OH− ion transport and subsequent depolarization of the membrane